Targeted anti-IL-13 therapies in asthma: current data and future perspectives
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2018.1427729
Abstract: ABSTRACT Introduction: The identification of patients with severe asthma who will benefit from a personalized management approach remains an unmet need. Interleukin-13 (IL-13) is a cytokine possessing a significant role in asthma pathogenesis and progression… read more here.
Keywords: targeted anti; therapies asthma; severe asthma; asthma current ... See more keywords
Severe asthma: Current management, targeted therapies and future directions—A roundtable report
Sign Up to like & getrecommendations! Published in 2017 at "Respirology"
DOI: 10.1111/resp.12957
Abstract: Asthma is a chronic respiratory disease characterized by respiratory symptoms, airway inflammation, airway obstruction and airway hyper‐responsiveness. Asthma is common and directly affects 10% of Australians, 1–5% of adults in Asia and 300 million people… read more here.
Keywords: current management; severe asthma; asthma current; management ... See more keywords
Late-onset asthma: current perspectives
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s125948
Abstract: Because the pathophysiology of asthma has diverse characteristics, to manage the disease effectively, it is important for clinicians to distinguish among the clinical phenotypes. Among them, adult-onset asthma, that is, late-onset asthma (LOA), is increasing… read more here.
Keywords: late onset; onset asthma; asthma current; current perspectives ... See more keywords